Key Financials Snapshot

TTM · Standalone · ₹ in Cr
Market Cap
₹228 Cr.
Stock P/E
913.2
P/B
11.1
Current Price
₹12.2
Book Value
₹ 1.1
Face Value
1
52W High
₹16.3
52W Low
₹ 2.5
Dividend Yield
0%

Integrated Proteins Overview

Business

Integrated Proteins Ltd. operates in the trading sector within India. The company's core business model involves acting as an intermediary for the sourcing, distribution, and sale of protein-related commodities. Given its name, it likely specializes in various forms of proteins, potentially including animal feed proteins (e.g., soybean meal, fish meal), food-grade proteins (e.g., soy protein isolates, wheat gluten), or other related agri-commodities. The company makes money through trading margins, which is the difference between its buying and selling prices, by leveraging its network of suppliers and buyers, market intelligence, and logistical capabilities.

Revenue Mix

While specific segment data is not available, based on the company name and industry, potential segments for Integrated Proteins Ltd. could include:

Animal Feed Proteins: Trading of protein ingredients used in animal nutrition.

Food & Industrial Proteins: Trading of proteins for human consumption or industrial applications.

Other Agri-Commodities: Potentially diversifying into trading other agricultural products related to its protein focus.

Revenue generation is primarily from the sale of these traded commodities.

Industry

The trading industry in India is characterized by its competitive and often fragmented nature, especially in agricultural commodities. Success relies heavily on efficient sourcing, strong logistical networks, deep market intelligence, and robust client relationships. Key players range from large global commodity houses to regional specialists and local brokers. Without specific market share data, Integrated Proteins Ltd. likely positions itself as a specialized player within the protein commodities segment, aiming to differentiate through reliable supply, competitive pricing, and efficient service within the Indian market.

MOAT

Trading companies generally possess limited sustainable competitive advantages. For Integrated Proteins Ltd., potential advantages could stem from:

Established Relationships: Long-standing and trusted relationships with a diverse base of suppliers and buyers, ensuring consistent deal flow.

Logistical Efficiency: An optimized supply chain, including warehousing and transportation, that minimizes costs and delivery times.

Market Intelligence: Superior real-time insights into supply-demand dynamics, pricing trends, and regulatory changes, enabling informed trading decisions.

Financial Strength: The ability to manage working capital effectively and offer favorable credit terms can be crucial in a high-volume, low-margin business.

Growth Drivers

Rising Protein Demand: Global and domestic population growth, increasing disposable incomes, and evolving dietary preferences are driving higher demand for protein.

Geographic Expansion: Entering new domestic regions or international markets for sourcing or distribution.

Product Diversification: Expanding the range of protein types or related agri-commodities traded.

Value-Added Services: Potentially offering basic processing, blending, or specific formulation services to customers.

Supply Chain Optimization: Continuous improvement in logistics and sourcing efficiency to enhance margins and competitiveness.

Risks

Commodity Price Volatility: Significant fluctuations in global and domestic protein commodity prices can severely impact trading margins and profitability.

Supply Chain Disruptions: Events such as adverse weather, geopolitical tensions, trade restrictions, or logistical bottlenecks can disrupt supply and raise costs.

Regulatory & Policy Changes: Changes in government policies regarding agriculture, trade, import/export duties, or food safety standards in India or target markets can affect operations.

Intense Competition: The fragmented nature of the trading industry leads to aggressive competition, potentially compressing margins.

Currency Fluctuations: For international trade, adverse movements in foreign exchange rates can erode profitability.

Working Capital Management: Trading businesses are capital intensive; inefficient management of working capital can strain liquidity.

Counterparty Risk: Risk of default by buyers or suppliers.

Management & Ownership

Specific details regarding Integrated Proteins Ltd.'s promoters, management quality, and ownership structure are not provided. Typically, Indian trading companies are often promoter-driven, with significant ownership held by the founding family or core group. The quality of management would depend on their experience in commodity markets, risk management capabilities, and ability to foster strong relationships.

Outlook

Integrated Proteins Ltd. operates in a fundamental yet challenging sector. The ongoing global demand for protein, driven by population growth and changing diets, provides a long-term tailwind. Success will hinge on the company's ability to navigate the inherent volatility of commodity markets, maintain efficient operations, and leverage strong supplier and customer relationships. A disciplined approach to risk management, particularly regarding price fluctuations and currency exposure, will be crucial. Expansion into new products or geographies, coupled with continuous optimization of its supply chain, could fuel growth. Conversely, intense competition, unforeseen supply chain disruptions, and adverse regulatory shifts pose significant challenges that could impact profitability and market position.

Integrated Proteins Share Price

Live · BSE · Inception: 1992
₹ | |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Standalone · annual

Integrated Proteins Quarterly Results

#(Fig in Cr.) Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Net Sales 0 0 0 0 21 0 4 0 6 11
Other Income 0 0 0 0 0 0 0 0 0 0
Total Income 0 0 0 0 22 0 4 0 6 11
Total Expenditure 0 0 0 0 21 0 4 0 5 10
Operating Profit 0 0 -0 0 0 0 0 -0 0 0
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 0 -0 -0 0 0 0 0 -0 0 0
Provision for Tax 0 -0 -0 0 0 0 0 0 0 0
Profit After Tax 0 -0 -0 0 0 0 0 -0 0 0
Adjustments 0 0 0 -0 -0 0 0 0 -0 0
Profit After Adjustments 0 -0 -0 0 0 0 0 -0 0 0
Adjusted Earnings Per Share 0 -0 -0 0 0.1 0 0 -0 0 0

Integrated Proteins Profit & Loss

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 0 0 0 0 0 0 0 0 0 0 21 21
Other Income 0 0 0 0 0 0 0 0 0 0 0 0
Total Income 0 0 0 0 0 0 0 0 0 0 22 21
Total Expenditure 0 0 0 0 0 0 0 0 0 0 21 19
Operating Profit 0 0 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 0 0 0 0 0 0 0 0 0 0 0 0
Provision for Tax 0 0 0 0 -0 0 0 0 0 0 0 0
Profit After Tax 0 0 0 0 0 0 0 0 0 0 0 0
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Adjusted Earnings Per Share 0 0 0 0 0 0 0 0 0 0 0.1 0

Integrated Proteins Balance Sheet

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 2 2 3 3 2 2 2 2 3 3 20
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0 0
Total Current Liabilities 0 0 0 0 0 0 0 0 0 0 12
Total Liabilities 3 3 3 3 3 3 3 3 3 3 32
Fixed Assets 1 1 1 1 1 0 0 0 0 0 0
Other Non-Current Assets 2 2 2 2 2 2 2 2 2 2 0
Total Current Assets 0 1 1 1 0 0 0 0 0 0 32
Total Assets 3 3 3 3 3 3 3 3 3 3 32

Integrated Proteins Cash Flow

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 0 0 0 0 0 0 0 0 0 0 0
Cash Flow from Operating Activities -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -24
Cash Flow from Investing Activities 0 0 0 0 0 0 0 0 -0 0 2
Cash Flow from Financing Activities 0 0 0 0 -0 0 0 0 0 -0 21
Net Cash Inflow / Outflow 0 0 -0 -0 -0 -0 -0 -0 -0 -0 0
Closing Cash & Cash Equivalent 0 0 0 0 0 0 0 0 0 0 0

Integrated Proteins Ratios

# Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 0.03 0.02 0.01 0 0.01 0 0.01 0.01 0.01 0.03 0.08
CEPS(Rs) 0.03 0.03 0.02 0.01 0.02 0.01 0.02 0.02 0.02 0.04 0.08
DPS(Rs) 0 0 0 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) 0.68 0.71 0.72 0.69 0.66 0.66 0.67 0.68 0.69 0.72 0.79
Core EBITDA Margin(%) -58.14 -77.64 0 0 0 0 0 0 -51.14 -49.87 0.43
EBIT Margin(%) 105.32 103.54 0 0 0 0 0 0 25.09 43.85 1.49
Pre Tax Margin(%) 101.4 102.4 0 0 0 0 0 0 25.03 43.81 1.49
PAT Margin (%) 101.4 102.4 0 0 0 0 0 0 18.5 37.62 1.16
Cash Profit Margin (%) 136.03 139.42 0 0 0 0 0 0 35.75 48.74 1.21
ROA(%) 3.48 3.17 1.76 0.45 0.95 0.22 0.82 1.38 1.12 3.22 1.42
ROE(%) 3.72 3.39 1.91 0.51 1.14 0.26 1 1.69 1.41 3.97 10.34
ROCE(%) 3.87 3.43 3.34 2.54 0.15 0.76 1.17 1.95 1.59 3.89 2.4
Receivable days 31.35 86.82 0 0 0 0 0 0 0 0 0
Inventory Days 0 0 0 0 0 0 0 0 0 0 0
Payable days 0 0 0 0 0 0 0 0 135.07 57.06 69.58
PER(x) 0 9.08 16.47 0 31.69 0 0 131.65 124.04 58.16 50.87
Price/Book(x) 0 0.3 0.31 0 0.37 0 0 2.21 1.74 2.27 5.01
Dividend Yield(%) 0 0 0 0 0 0 0 0 0 0 0
EV/Net Sales(x) 36 3.13 0 0 0 0 0 0 23.95 21.76 0.77
EV/Core EBITDA(x) 25.72 2.23 2.77 30 13.79 63.29 55.09 62.02 56.56 39.59 50.22
Net Sales Growth(%) 22.73 -6.48 -100 0 0 0 0 0 0 42.16 8954.89
EBIT Growth(%) -17.38 -8.06 0.05 -23.18 -94.09 386.54 55.12 72.13 -15.18 148.45 206.92
PAT Growth(%) -20.33 -5.56 -42.3 -74.44 102.59 -77.53 281.19 72.17 -15.34 189 179.96
EPS Growth(%) -20.32 -5.57 -42.3 -71.99 102.89 -77.49 280.32 72.17 -15.3 188.81 180.01
Debt/Equity(x) 0 0 0 0 0 0 0.01 0.03 0.08 0.01 1.36
Current Ratio(x) 2.54 2.75 2.29 12.33 3.72 3.05 1.14 0.72 0.84 1.2 2.64
Quick Ratio(x) 2.54 2.75 2.29 12.33 3.72 3.05 1.14 0.72 0.84 1.2 2.64
Interest Cover(x) 26.85 90.28 501.68 294.88 5.79 371.96 0 494 419 1041 3195
Total Debt/Mcap(x) 0 0 0 0 0 0 0 0.02 0.05 0.01 0.31

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR — — — —
Operating Profit CAGR — — — —
PAT CAGR — — — —
Share Price CAGR +337% +122% +103% +19%
ROE Average +10% +5% +4% +3%
ROCE Average +2% +3% +2% +2%

Integrated Proteins Shareholding Pattern

Latest · Jun 2026
100% held
Promoters 2.24 %
FII 0 %
DII (MF + Insurance) 0 %
Public (retail) 97.76 %
# Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Promoter 46.2946.2946.2922.413.0413.0413.042.232.232.24
FII 0000000000
DII 0000000000
Public 53.7153.7153.7177.686.9686.9686.9697.7797.7797.76
Others 0000000000
Total 100100100100100100100100100100

Integrated Proteins Peer Comparison

Integrated Proteins Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

Integrated Proteins Pros & Cons

Pros

Cons

  • Promoter holding is low: 2.24%.
  • Company has a low return on equity of 5% over the last 3 years.
  • Debtor days have increased from 57.06 to 69.58days.
  • Stock is trading at 11.1 times its book value.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp